Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813678
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-04-03
Brief Title:
A Long-term Post-marketing Safety Study of Palynziq in Patients With PKU PALace
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-06
Start Date Type:
ACTUAL
Primary Completion Date:
2033-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-03
First Submit QC Date:
April 3 2023
Study First Post Date:
2023-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-10
Last Update Post Date:
2024-05-13
Last Update Post Date Type:
ACTUAL